Certain antiretroviral protease inhibitors (eg, atazanavir) used in the  treatment  of  the human immunodeficiency virus (HIV) infection can lead to increased levels of unconjugated hyperbilirubinaemia.


 
Modified 8 months ago on Jun 18, 2019
MoreVitaminovPRO ranked added it 10 months ago on Apr 8, 2019